Bolkun, L.; Tynecka, M.; Wasiluk, T.; Piszcz, J.; Starosz, A.; Grubczak, K.; Moniuszko, M.; Eljaszewicz, A.
A Proliferation-Inducing Ligand and B-Cell Activating Factor Are Upregulated in Patients with Essential Thrombocythemia. J. Clin. Med. 2022, 11, 4663.
https://doi.org/10.3390/jcm11164663
AMA Style
Bolkun L, Tynecka M, Wasiluk T, Piszcz J, Starosz A, Grubczak K, Moniuszko M, Eljaszewicz A.
A Proliferation-Inducing Ligand and B-Cell Activating Factor Are Upregulated in Patients with Essential Thrombocythemia. Journal of Clinical Medicine. 2022; 11(16):4663.
https://doi.org/10.3390/jcm11164663
Chicago/Turabian Style
Bolkun, Lukasz, Marlena Tynecka, Tomasz Wasiluk, Jaroslaw Piszcz, Aleksandra Starosz, Kamil Grubczak, Marcin Moniuszko, and Andrzej Eljaszewicz.
2022. "A Proliferation-Inducing Ligand and B-Cell Activating Factor Are Upregulated in Patients with Essential Thrombocythemia" Journal of Clinical Medicine 11, no. 16: 4663.
https://doi.org/10.3390/jcm11164663
APA Style
Bolkun, L., Tynecka, M., Wasiluk, T., Piszcz, J., Starosz, A., Grubczak, K., Moniuszko, M., & Eljaszewicz, A.
(2022). A Proliferation-Inducing Ligand and B-Cell Activating Factor Are Upregulated in Patients with Essential Thrombocythemia. Journal of Clinical Medicine, 11(16), 4663.
https://doi.org/10.3390/jcm11164663